Drillbig1 Posted - 04/29/24

$APLM just another day!

Jabed206 Posted - 04/29/24

$APLM liquidity so bad, no one wants to invest in this shit

RollingDollar Posted - 04/29/24

$APLM

entrypt Posted - 04/26/24

$APLM NEWS on an approval in China and APLM goes no where! You have $5>>6 targets by investment firms and APLM goes no where! Listening to "ANAL"LYST is dangerous for your wealth!

Slambucket Posted - 04/25/24

$APLM - Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene https://finance.yahoo.com/news/apollomics-announces-approval-vebreltinib-china-123000507.html

entrypt Posted - 04/25/24

$APLM Seriously cannot get past .60 let alone over $1.00!!

Dieseld28 Posted - 04/25/24

$APLM next too $1 👀

RollingDollar Posted - 04/25/24

$APLM

Stock_Titan Posted - 04/25/24

$APLM $APLMW Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene https://www.stocktitan.net/news/APLM/apollomics-announces-approval-of-vebreltinib-in-china-as-a-first-in-9gx6wc4qoxcq.html

entrypt Posted - 04/25/24

$APLM "FAKE POP"!! MM's run the stock to .56 this AM to sell shares from the Shelf Offering!! And of course no follow through no news!

Slambucket Posted - 04/25/24

$APLM - Volume Pre-market

Slambucket Posted - 04/24/24

@pmcd777 Hopefully this will be frosting on top of uproleselan data for $APLM

Slambucket Posted - 04/24/24

$APLM - One oral and one poster presentation at #ASCO. @apollomics has to do something to get their company and stock back in track. Hopefully this will help. #Vebreltinib

trollkinge Posted - 04/22/24

$APLM Taking a position for swing play

pmcd777 Posted - 04/21/24

$APLM anyone paying attention to the recent filings? https://www.sec.gov/edgar/browse/?CIK=1944885 @Slambucket fyi

jiFbB Posted - 04/19/24

$APLM shameless scam!!!

Drillbig1 Posted - 04/18/24

$APLM There’s the spike so do down 3% tomorrow. It’s the same play everyday. The system is broken there’s no doubt.😭

entrypt Posted - 04/18/24

$APLM Stock had so much promise but cannot get past .60! No value in their product by the market!

timelesstrades Posted - 04/16/24

$APLM something is cookin

RollingDollar Posted - 04/16/24

$APLM

Slambucket Posted - 04/14/24

$GLYC $APLM https://x.com/healthndpharma/status/1778528887749947511?s=46

Slambucket Posted - 04/11/24

$APLM I had no idea Orbimed was invested here. I’m still holding my GLYC sympathy trade here, but I find Orbimed’s involvement a positive.

DonCorleone77 Posted - 04/10/24

$APLM 2 of 2 - Apollomics presents vebreltinib data at AACR meeting ....tumor models at clinically relevant drug levels," demonstrated that vebreltinib is a novel potent and selective MET kinase inhibitor showing promising preclinical activity against patient-derived tumors from diverse organ sites and genomic alterations such as MET exon 14 skipping, MET fusion, MET amplification, or MET and hepatocyte growth factor over-expression at clinically relevant drug levels, providing proof-of-concepts for continued clinical development. The second poster presented, titled, "Dependence of EGFR-mutant NSCLC on MET as demonstrated by vebreltinib, a novel and selective brain-penetrating MET kinase inhibitor," demonstrated that adding vebreltinib to EGFR therapies overcomes MET-amplification dependent resistance with durable effect or prevents MET-dependent resistance to maximize therapeutic benefits.

DonCorleone77 Posted - 04/10/24

$APLM 1 of 2 - Apollomics presents vebreltinib data at AACR meeting Apollomics presented two posters at the 2024 American Association for Cancer Research Annual Meeting, held April 5-10, 2024 in San Diego, Calif. "Vebreltinib's selectivity and high in vivo potency against multiple tumor types in a variety of patient-derived tumor models demonstrate its potential to treat a variety of MET-altered tumors, as a single agent or in combination," said Guo-Liang Yu, PhD, Chairman and Chief Executive Officer of Apollomics. "Based on preclinical models established from patients, we believe vebreltinib may also provide meaningful clinical benefit towards overcoming or preventing MET-amplification dependent resistance in EGFR-positive non-small cell lung cancer patients." The first poster presented, titled, "Vebreltinib: A novel brain-penetrating MET kinase inhibitor demonstrates the mechanism of action and pharmacological anti-tumor activity in diverse patient-derived MET-dysregulated....

Stock_Titan Posted - 04/10/24

$APLM $APLMW Apollomics Presents Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting https://www.stocktitan.net/news/APLM/apollomics-presents-vebreltinib-data-at-the-2024-american-aylktjbeawm8.html

entrypt Posted - 04/05/24

$APLM Expecting good news out of this conference that starts today 5th>10! $5 and $6 price targets! Selling for .60! Novel Oncology Therapies to address Difficult-to-Treat Cancers!

Drillbig1 Posted - 04/04/24

$APLM

entrypt Posted - 04/04/24

$APLM Has This board has gone silent? Expect news from the conference from April 5-10! If anyone is out there good luck!

Drillbig1 Posted - 04/03/24

$APLM Come on Plunkett do something don’t just let it tank.

LAMC1 Posted - 4 weeks ago

$APLM 4hr 👀